Table 1.
Demographic and clinical characteristics | Baseline |
---|---|
Number of patients | 18 |
Age y, mean±SD | 54 ± 11.7 |
Female, n (%) | 7 (38.9) |
Weight Kg, mean±SD | 72.44±11.92 |
History of smoking (former), n (%) | 2 (11.1) |
Age onset y, mean±SD | 36.3±15.84 |
Total serum IgE KU/l, mean±SD | 227.22±300.82 |
Positive bronchodilator response, n (%) | 17 (94.4) |
Positive bronchodilator response %, mean±SD | 16.7±8.3 |
T2 high phenotype | |
Only eosinophilic, n (%) | 16 (88.9) |
Eosinophilic and allergic, n (%) | 2 (11.1) |
OCS treatment | |
Patients taking OCS at least 6 months/year n (%) | 18(100) |
Comorbidities | |
CRSwNP, n (%) | 10 (55.,6) |
GERD, n (%) | 10 (55.6) |
Bronchiectasis, n (%) | 6 (33.3) |
T2 high, type 2 high; OCS, oral corticosteroids; CRSwNP, chronic rhinosinusitis with nasal polyposis; GERD, gastroesophageal reflux disease.